Diginova Health Solutions, a digital healthcare start-up based at the DIFC, announced today its partnership with Finnish firm Cardiolyse, to bring its award-winning cloud ECG & HRV analytics platform in the UAE. Cardiolyse is an ECG & HRV predictive analytics platform for real-time remote heart health and fatigue risks monitoring, providing plain personalised reports, detection and up to two months data-based prognosis on dangerous heart events.
“An estimated 80% of cardiovascular disease (CVD), including heart disease and stroke, are preventable, but sadly it remains one of the leading causes of death in the UAE and around the world. CVD complications are accountable for more than 50% of all deaths among people with diabetes, which unfortunately is a grim reality in the UAE, with over a million people living with it”, says Dr. Sarper Tanli, Co-Founder and CEO of Diginova Health Solutions.
Cardiolyse's proprietary patent-pending machine-learning algorithms process all vital ECG parameters to create an alerting feature that notifies both patient and his doctor on increased stroke or heart attack risks, enabling the prevention of critical heart events up to two months before they occur. As a device-agnostic cloud platform, Cardiolyse cuts off the need for complicated time-consuming integration by pairing its solution with any type of digital ECG device via universal API (application programming interface). The ecosystem is comprised of customized web dashboards for both patients and physicians, as well as independent Android and iOS applications for each user type needs.
"Global healthcare is in obvious and desperate need for disruptive technologies, and we are grateful for the opportunity to partner with Diginova in bringing Cardiolyse to the UAE to support the region’s digital transformation as it serves the emerging challenges of both healthcare providers and personal health-conscious patients", commented Anna Starynska, Co-Founder and CEO at Cardiolyse. "Our primary goal here is to provide timely and data-driven insights for physicians and cardiologists to support the cost-effective patient-centric diagnosticating approach and more accurate self-care solutions for patients.
Dr. Sarper adds, “The MENA digital healthcare space is severely underserved, with per capita spending lagging behind EU and the US by as much as 60%. Our job at Diginova is to identify gaps in the market and facilitate digital health products and solutions through entrepreneurs and accelerator programs. Through our partnership with Cardiolyse we are committed to amplify the impact and scale of digital heath solutions in the region.
Diginova also confirmed that the UAE launch of Cardiolyse will be followed by a region-wide entry across the GCC, starting immediately with KSA.
Diginova Health Solutions Ltd. is a digital health start-up founded in 2020 by Dr. Sarper Tanli, a healthcare specialist with over 28 years of experience, including healthcare investments and digital health implementation in the US and the Middle East, and Utku Balik, an ex-strategy consultant and banker with over 18 years of experience in strategy, business development and financial management. Diginova is registered in Dubai International Financial Centre (DIFC).
Diginova aims to become the leading platform that incubates, supports and invests in the most promising digital health startups. It also closely collaborates with governments, regulators and accelerators to improve the well-being of communities in the Middle East and North Africa (MENA) region.
Cardiolyse is an award-winning e-healthcare start-up company based in the EU. It specialises in delivering holistic approach in preventing heart disorders for elevated risk groups, using innovative and clinically proven machine-learning algorithms.
It was founded in 2016 by Anna Starynska, a computer science and applied technologies expert and a distinguished project manager with more than 25 years of experience in leading multinational complex projects across the EU; and by Dr. Illya Chaikovsky, a published scientist, with more than 30 years of experience in practicing cardiology.
Cardiolyse is the WINNER of the AMGEN Challenge of 2020 EIT Health Startups Meet Pharma. The Amgen Challenge is dedicated to encouraging continuity in treatment strategy and treatment optimization for post-myocardial infraction patients.
For more information visit cardiolyse.com